Pulmonary disposition of vancomycin nebulized as lipid vesicles in rats

Journal of Antibiotics

Volumn 66, Issue 8, 2013, Pages 447-451

  De Jesus Valle M J ^a   González, J Garavís ^a   López, F González ^a   Navarro, A Sánchez ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

Author keywords

Chitosan; Inhalatory administration; Lipid vesicles; Pulmonary delivery; Pulmonary drug disposition; Vancomycin

Indexed keywords

CHITOSAN; LIPOSOME; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; DRUG TRANSPORT; LIPID VESICLE; LUNG FLUID; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; BRONCHOALVEOLAR LAVAGE FLUID; CHITOSAN; DRUG DELIVERY SYSTEMS; LIPOSOMES; LUNG; MALE; NEBULIZERS AND VAPORIZERS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; VANCOMYCIN;

EID: 84883214533     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2013.32     Document Type: Article

References (30)

1. Albasarah, Y. Y., Somavarapu, S., Stapleton, P. & Taylor, K. M. G. Chitosan-coated antifungal formulations for nebulisation. J. Pharm. Pharmacol. 62, 821-828 (2010).
2. Vyas, S. P., Quraishi, S., Gupta, S. & Jaganathan, K. S. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int. J. Pharm. 296, 12-25 (2005). (Pubitemid 40693368)
3. Chimote, G. & Banerjee, R. In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as adjunct therapy in pulmonary tuberculosis. J. Biomed. Mater. Res. B Appl. Biomater 94B (1), 1-10 (2010).
4. Vyas, S. P., Kannan, M. E., Jain, S., Mishra, V. & Singh, P. Design of liposomal aerosol for improves delivery of rifampicin to alveolar macrophages. Int. J. Pharm. 269, 37-49 (2004). (Pubitemid 38035210)
5. Gaur, P. K. et al. In-situ formation of liposome of rifampicin: better availability for better treatment. Curr. Drug Deliv. 6, 461-468 (2009).
6. Chono, S., Tanino, T., Seki, T. & Morimoto, K. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. J. Control Release 127, 50-58 (2008).
7. Pinto-Alphandary, H., Andremont, A. & Couvreur, P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int. J. Antimicrob. Agents 13, 155-168 (2000).
8. Parmar, J. J. et al. Development and evaluation of inhalational liposomal system of budesonide for better management of asthma. Indian J. Pharm. Sci. 72 (4), 442-448 (2010).
9. Stark, B., Debbage, P., Andreae, F., Masgoeller, W. & Prassl, R. Association of vasoactive peptide with polymer-graftes liposomes: structural aspects for pulmonary delivery. Biochim. Biophys. Acta. 1768, 705-714 (2007). (Pubitemid 46275600)
10. Cattel, L., Ceruti, M. & Dosio, F. From conventional to stealth liposomes: a new frontier in cancer chemotherapy. Tumori 89 (3), 237-249 (2003). (Pubitemid 37014112)
11. Zhao, L., Ye, Y., Li, J. & Wei, Y. Preparation and the in-vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs. J. Pharm. Pharmacol. 63, 80-86 (2011).
12. Li, P. et al. A novel cationic liposome formulation for efficient gene delivery via pulmonary route. Nanotechnology 22, 1-10 (2011).
13. Bi, R., Shao, W., Wang, Q. & Zhang, N. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. J. Drug Target 16 (9), 639-648 (2008).
14. Chono, S., Fukuchi, R., Seki, T. & Morimoto, K. Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. J. Control Release 137, 104-108 (2009).
15. Bai, S. & Ahsan, F. Inhalable liposomes of low molecular weight heparin for the treatment of venous thromboempolism. J. Pharm. Sci. 99 (11), 4554-4564 (2010).
16. Bai, S., Gupta, V. & Ahsan, F. Cationic liposomes as carries for aerosolized formulations of an anionic drug: safety and efficacy study. Eur. J. Pharm. Sci. 38, 165-171 (2009).
17. Oyarzun-Ampuero, F. A., Brea, J., Loza, M. I., Torres, D. & Alonso, M. J. Chitosanhyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int. J. Pharm. 381, 122-129 (2009).
18. De Jesú s Valle, M. J., Dinis-Oliveira, R. J., Carvalho, F., Bastos, M. L. & Sánchez, N. A. Toxicological evaluation of lactose and chitosan delivered by inhalation. J. Biomater. Sci. Polym. Ed. 19 (3), 387-397 (2008a).
19. Bangham, A. D., Standishand, M. M. & Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13, 238-252 (1965).
20. De Jesú s Valle, M. J., López, F. G. & Navarro, A. S. Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study. J. Pharm. Biomed. Anal. 48 (3), 838-839 (2008b).
21. Lee, H. B. & Blaufox, M. D. Blood volume in the rat. J. Nucl. Med. 25, 72-76 (1985). (Pubitemid 15161428)
22. Beckmann, J. et al. Tissue concentrations of vancomycin and moxifloxacin in periprosthetic infection in rats. Acta. Orthop. 78 (6), 766-773 (2007). (Pubitemid 351185597)
23. Engineer, M. S., Ho, D. H. & Bodey, G. P. Comparison of vancomycin disposition in rats with normal and abnormal renal functions. Antimicrob. Agents Chemother. 20 (6), 718-722 (1981). (Pubitemid 12188186)
24. Milton, S. Estadística para biología y ciencias de la salud 3th edn (McGraw Hill, Interamericana, Madrid, 2007).
25. Al-Quadi, S., Grenha, A., Carrión-Recio, D., Seijo, B. & Remun?an-López, C. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J. Control Release 157, 383-390 (2012).
26. Yamamoto, H., Kuno, Y., Sugimoto, S., Takeuchi, H. & Kawashima, Y. Surface modified PLG nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J. Control Release 102, 373-381 (2005). (Pubitemid 40093760)
27. Lim, S. T., Forbes, B., Martin, G. P. & Brown, M. B. In vitro and in vivo characterization of nobel microparticulates based on hyaluronan and chitosan hydroglutamate. AAPS Pharm. Sci. Tech. 2, 14 (2001).
28. Florea, B. I., Thanou, H. E., Junginger, G. & Borchard, G. Enhancement of bronchial ocreotide absorption by chitosan and N-trimethylchitosan shows linear in vitro/in vivo correlation. J. Control Release 110, 353-361 (2006). (Pubitemid 41827489)
29. Conti, D. S., Bharatwaj, B., Brewer, D. & Da Rocha, S. R. P. Propellant-based inhalers for the non-invasive delivery of genes via oral inhalation. J. Control Release 157, 406-417 (2012).
30. Elyasi, S., Khalili, H., Dashti-Khavidaki, S. & Mohammadpour, A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur. J. Clin. Pharmacol. 68, 1243-1255 (2012).